Navigation Links
A 'USB' for medical diagnosis?
Date:11/29/2010

Biomedical engineers at UC Davis have developed a plug-in interface for the microfluidic chips that will form the basis of the next generation of compact medical devices. They hope that the "fit to flow" interface will become as ubiquitous as the USB interface for computer peripherals.

UC Davis filed a provisional patent on the invention Nov. 1. A paper describing the devices was published online Nov. 25 by the journal Lab on a Chip.

"We think there is a huge need for an interface to bridge microfluidics to electronic devices," said Tingrui Pan, assistant professor of biomedical engineering at UC Davis. Pan and graduate student Arnold Chen - invented the chip and co-authored the paper.

Microfluidic devices use channels as small as a few micrometers across, cut into a plastic membrane, to carry out biological or chemical tests on a miniature scale. They could be used, for example, in compact devices used for medical diagnosis, food safety or environmental monitoring.

Cell phones with increasingly sophisticated cameras could be turned into microscopes that could read such tests in the field.

But it is difficult to connect these chips to electronic devices that can read the results of a test and store, display or transmit it.

Pan thinks that the fit-to-flow connectors can be integrated with a standard peripheral component interconnect (PCI) device commonly used in consumer electronics, while an embedded micropump will provide on-demand, self-propelled microfluidic operations. With this standard connection scheme, chips that carry out different tests could be plugged into the same device -- such as a cell phone, PDA or laptop -- to read the results.


'/>"/>

Contact: Andy Fell
ahfell@ucdavis.edu
530-752-4533
University of California - Davis
Source:Eurekalert  

Page: 1

Related biology news :

1. Futronic Launches FS90 USB2.0 Mini Fingerprint Scanner
2. Futronic Launches FS90 USB2.0 Mini Fingerprint Scanner
3. Medical imaging breakthrough uses light and sound to see microscopic details inside our bodies
4. Program for young students increases interest in college attendance and medical careers
5. Biomedical and health professionals converge in D.C. to absorb new findings in science of informatics
6. Technology developed at Queens University allows medical workers to better assess brain injuries
7. Medical research and magic come together
8. Fish gelatin: Ultra-high-tech biomedical uses ahead?
9. Columbia University Medical Center announces 2010 Katz Prizes in cardiovascular research
10. Built-in timer for improving accuracy of cost saving paper-strip medical tests
11. UMass Medical School study points to genetic link in apnea of prematurity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A 'USB' for medical diagnosis?
(Date:7/10/2014)... in New Mexico, nearly every public golf course is ... potable water supplies. Across the U.S. Southwest as a ... treated effluent. Reusing the effluent increases the sustainability of ... alike fertilize their lawns during the growing season. The ... State University turfgrass expert has a new vision for ...
(Date:7/10/2014)... NEW YORK , June 27, 2014 /PRNewswire/ ... against Provectus Biopharmaceuticals, Inc. ("Provectus" or the "Company")(NYSE-MKT: ... action, filed in United States District Court, Middle ... Division, is on behalf of a class consisting ... otherwise acquired Provectus securities between December 17, 2013 ...
(Date:7/10/2014)... CORAL SPRINGS, Florida , July 1, 2014 ... smart wallets pave way for convenience and improved security: NXT-ID, ... Google Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ... ) and MasterCard Corporation (NYSE: MA) NXT-ID, Inc., (OTCQB: ... market, is pleased to announce that the second series of ...
Breaking Biology News(10 mins):'Tailored' water -- the latest in lawn care 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 4Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 5
... of the Alps, the Andes and the Himalayas in size ... hidden under the world,s oceans. Now in a special issue ... life on these submerged mountain ranges and reveal why these ... bathymetry of our oceans is now resolved at a scale ...
... ARBOR, Mich. -- Physician,s confidence in their abilities to counsel ... to their own personal habits, according to a study by ... depended on a doctor,s own exercise time, being overweight, and ... about diet and exercise. The study, published online ahead ...
... at Huntsman Cancer Institute (HCI) at the University of Utah ... maintenance and repair of the cell,s cytoskeleton, or internal framework, ... The research has implications for cancer, as well as other ... disease. The research was published in the Sep. 14, 2010, ...
Cached Biology News:Marine scientists unveil the mystery of life on undersea mountains 2Doctor's health habits affect patient counseling 2Study offers first explanation of how cells rapidly repair and maintain structure 2
(Date:7/12/2014)... Albany, New York (PRWEB) July 12, 2014 ... market analysis for various reagents used in ... biotechnology is driving the life science reagents ... this study include manufacturers and providers of ... Science Reagents Market Report: http://www.transparencymarketresearch.com/life-sciences-reagents-analytical-reagents.html . ...
(Date:7/11/2014)... , July 11, 2014 , Not ... in, into or from any jurisdiction where to do so ... jurisdiction.  Shire plc ("Shire" or the "Company") (LSE: ... this afternoon.  Shire confirms it has held a meeting with ... by Shire without the prior agreement or approval of AbbVie. ...
(Date:7/11/2014)... 11, 2014 BCC Research ( http://www.bccresearch.com ... POLYMERASE CHAIN REACTION (PCR) TECHNOLOGY: GLOBAL MARKETS , the ... reached nearly $140 billion in 2013. This is estimated ... five-year compound annual growth rate (CAGR) of 28.6%. , ... interesting and exciting possibilities within the broader PCR field. ...
(Date:7/11/2014)... - Sunovion Pharmaceuticals Canada Inc. (Sunovion) today announced that ... use as a once-daily adjunctive therapy for the treatment ... not satisfactorily controlled with conventional therapy.  APTIOM TM ... years of age. Epilepsy is one ... Epilepsy Canada, it affects 0.6% of the population and ...
Breaking Biology Technology:Transparency Market Research: Life Science Reagents Market- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis and Chromatography 2Transparency Market Research: Life Science Reagents Market- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis and Chromatography 3Shire plc - Statement re: Media Speculation 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4
... 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ... has been completed in the Phase II component of ... paclitaxel/carboplatin for patients with advanced cancers. The principal investigators ... Institute of Cancer Research, London, England, and Dr. Geoff ...
... statistical analysis technique that identifies and removes systematic ... could lead to more precise and reliable measurement ... industrial applications. Known as sequential profile adjustment ... the amount of experimental data required to make ...
... SHANGHAI, July 1 /PRNewswire-Asia/ -- WuXi PharmaTech ... had received an award from BASF for,excellent service and outstanding ... ingredients. , (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ... for a good CRO collaboration partner for years, and,today I ...
Cached Biology Technology:Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carboplatin Head and Neck Cancer Trial 2New statistical technique improves precision of nanotechnology data 2New statistical technique improves precision of nanotechnology data 3New statistical technique improves precision of nanotechnology data 4WuXi PharmaTech Receives Award from BASF 2
...
Mouse polyclonal antibody to PRDM2 - PR domain containing 2, with ZNF domain...
Anti Human S14G-Humanin Polyclonal Antibody...
... LABTrack provides a familiar interface for ... and warehousing. The transition from paper ... transparent. LABTrack contains an integrated ... and rules mechanism. These functions allow ...
Biology Products: